Systematic interrogation of 3q26 identifies TLOC1 and SKIL as cancer drivers

Cancer Discovery

Volumn 3, Issue 9, 2013, Pages 1044-1057

  Hagerstrand, Daniel ^a   Tong, Alexander ^a   Schumacher, Steven E ^b,e   Ilic, Nina ^a   Shen, Rhine R ^a   Cheung, Hiu Wing ^a,e   Vazquez, Francisca ^a,e   Shrestha, Yashaswi ^a,e   Kim, So Young ^a,f   Giacomelli, Andrew O ^a   Rosenbluh, Joseph ^a,e   Schinzel, Anna C ^a   Spardy, Nicole A ^a   Barbie, David A ^a,e   Mermel, Craig H ^a,e   Weir, Barbara A ^e   Garraway, Levi A ^a,c,e   Tamayo, Pablo ^e   Mesirov, Jill P ^e   Beroukhim, Rameen ^a,b,c,e   Hahn, William C ^a,c,d,e   more..

^a Fenway Health   (United States)

^b Departments of Cancer Biology   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^f DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAP BINDING PROTEIN; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR SOX2;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CARCINOGENESIS; CELL INVASION; CELL PROLIFERATION; CHROMOSOME 3Q; CHROMOSOME 3Q26; CONTROLLED STUDY; COPY NUMBER VARIATION; GAIN OF FUNCTION MUTATION; GENE EXPRESSION; GENETIC SCREENING; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LUNG NON SMALL CELL CANCER; MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; OVARY CANCER; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION; SKIL GENE; TLOC1 GENE; TUMOR GENE; TUMOR GROWTH; UPREGULATION;

BREAST NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMOSOMES, HUMAN, PAIR 3; DEAD-BOX RNA HELICASES; DNA COPY NUMBER VARIATIONS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; MAMMARY GLANDS, HUMAN; MEMBRANE TRANSPORT PROTEINS; NEOPLASM INVASIVENESS; NEOPLASMS; OVARIAN NEOPLASMS; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS;

EID: 84885230363     PISSN: 21598274     EISSN: 21598290     Source Type: Journal    
DOI: 10.1158/2159-8290.CD-12-0592     Document Type: Article

References (55)

1. Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, DonovanJ, et al. The landscape of somatic copy-number alteration across human cancers. Nature 2010; 463: 899-905.
2. TCGA. Comprehensive genomic characterization defi nes human glioblastoma genes and core pathways. Nature 2008; 455: 1061-8.
3. Woenckhaus J, Steger K, Werner E, Fenic I, Gamerdinger U, Dreyer T, et al. Genomic gain of PIK3CA and increased expression of p110alpha are associated with progression of dysplasia into invasive squamous cell carcinoma. J Pathol 2002; 198: 335-42.
4. Bass AJ, Watanabe H, Mermel CH, Yu S, Perner S, Verhaak RG, et al. SOX2 is an amplifi ed lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat Genet 2009; 41: 1238-42.
5. Massion PP, Taflan PM, Jamshedur Rahman SM, Yildiz P, Shyr Y, Edgerton ME, et al. Significance of p63 amplification and overexpression in lung cancer development and prognosis. Cancer Res 2003; 63: 7113-7121.
6. Broad Institute. Tumorscape: copy number alterations across multiple cancer types. [cited 2012 Dec 22]. Available from: http://www.broadinstitute.org/tumorscape.
7. Memorial Sloan-Kettering Cancer Center. cBioPortal for cancer genomics. [cited 2012 March 22]. Available from: http://www.cbioportal.org/public-portal/.
8. Luo B, Cheung HW, Subramanian A, Sharifnia T, Okamoto M, Yang X, et al. Highly parallel identifi cation of essential genes in cancer cells. Proc Natl Acad Sci U S A 2008; 105: 20380-5.
9. Boehm JS, Zhao JJ, Yao J, Kim SY, Firestein R, Dunn IF, et al. Integrative genomic approaches identify IKBKE as a breast cancer oncogene. Cell 2007; 129: 1065-79.
10. Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S, et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 2012; 483: 603-7.
11. Rothblatt JA, Deshaies RJ, Sanders SL, Daum G, Schekman R. Multiple genes are required for proper insertion of secretoryproteins into the endoplasmic reticulum in yeast. J Cell Biol 1989; 109: 2641-52.
12. Wilkinson BM, Regnacq M, Stirling CJ. Protein translocation across the membrane of the endoplasmic reticulum. J Membr Biol 1997; 155: 189-97.
13. Muller L, de Escauriaza MD, Lajoie P, Theis M, Jung M, Muller A et al. Evolutionary gain of function for the ER membrane protein Sec62 from yeast to humans. Mol Biol Cell 2010; 21: 691-703.
14. Panzner S, Dreier L, Hartmann E, Kostka S, Rapoport TA. Posttranslationalprotein transport in yeast reconstituted with a purifi edcomplex of Sec proteins and Kar2p. Cell 1995; 81: 561-70.
15. Yao L, Yan X, Dong H, Nelson DR, Liu C, Li X. Expression of an IRF-3fusion protein and mouse estrogen receptor, inhibits hepatitis C viral replication in RIG-I-defi cient Huh 7.5 cells. Virol J 2011; 8: 445.
16. Asano K, Kinzy TG, Merrick WC, Hershey JW. Conservation and diversity of eukaryotic translation initiation factor eIF3. J Biol Chem 1997; 272: 1101-9.
17. Shih JW, Tsai TY, Chao CH, Wu Lee YH. Candidate tumor suppressor DDX3 RNA helicase specifi cally represses cap-dependent translationby acting as an eIF4E inhibitory protein. Oncogene 2008; 27: 700-14.
18. Hosoda N, Lejeune F, Maquat LE. Evidence that poly(A) binding protein C1 binds nuclear pre-mRNA poly(A) tails. Mol Cell Biol2006; 26: 3085-97.
19. Venkatesan A, Sharma R, Dasgupta A. Cell cycle regulation of hepatitis C and encephalomyocarditis virus internal ribosome entry sitemediated translation in human embryonic kidney 293 cells. Virus Res 2003; 94: 85-95.
20. Gingras AC, Gygi SP, Raught B, Polakiewicz RD, Abraham RT, Hoekstra MF, et al. Regulation of 4E-BP1 phosphorylation: a noveltwo-step mechanism. Genes Dev 1999; 13: 1422-37.
21. Stroschein SL, Wang W, Zhou S, Zhou Q, Luo K. Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein. Science 1999; 286: 771-4.
22. Iacobuzio-Donahue CA, Wilentz RE, Argani P, Yeo CJ, Cameron JL, Kern SE, et al. Dpc4 protein in mucinous cystic neoplasms of the pancreas: frequent loss of expression in invasive carcinomas suggests a role in genetic progression. Am J Surg Pathol 2000; 24: 1544-8.
23. Gould J, Getz G, Monti S, Reich M, Mesirov JP. Comparative gene marker selection suite. Bioinformatics 2006; 22: 1924-1925.
24. Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 2007; 7: 415-28.
25. Albino D, Longoni N, Curti L, Mello-Grand M, Pinton S, Civenni G, et al. ESE3/EHF controls epithelial cell differentiation and its loss leads to prostate tumors with mesenchymal and stem-like features. Cancer Res 2012; 72: 2889-900.
26. Zhang H, Meng F, Liu G, Zhang B, Zhu J, Wu F, et al. Forkhead transcription factor foxq1 promotes epithelial-mesenchymal transition and breast cancer metastasis. Cancer Res 2011; 71: 1292-301.
27. Kojima T, Takasawa A, Kyuno D, Ito T, Yamaguchi H, Hirata K, et al. Downregulation of tight junction-associated MARVEL protein marvelD3 during epithelial-mesenchymal transition in human pancreatic cancer cells. Exp Cell Res 2011; 317: 2288-2298.
28. Cheng H, Fukushima T, Takahashi N, Tanaka H, Kataoka H. Hepatocyte growth factor activator inhibitor type 1 regulates epithelial tomesenchymal transition through membrane-bound serine proteinases Cancer Res 2009; 69: 1828-35.
29. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004; 117: 927-39.
30. Taube JH, Herschkowitz JI, Komurov K, Zhou AY, Gupta S, Yang J, et al. Core epithelial-to-mesenchymal transition interactome geneexpression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc Natl Acad Sci U S A 2010; 107: 15449-54.
31. Nieto MA. The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol 2002; 3: 155-66.
32. Akagi I, Miyashita M, Makino H, Nomura T, Hagiwara N, Takahashi K, et al. SnoN overexpression is predictive of poor survival inpatients with esophageal squamous cell carcinoma. Ann Surg Oncol 2008; 15: 2965-75.
33. Xue W, Kitzing T, Roessler S, Zuber J, Krasnitz A, Schultz N, et al. A cluster of cooperating tumor-suppressor gene candidates in chromosomal deletions. Proc Natl Acad Sci U S A 2012; 109: 8212-7.
34. Soto-Rifo R, Rubilar PS, Limousin T, de Breyne S, Decimo D, Ohlmann T. DEAD-box protein DDX3 associates with eIF4F to promote translation of selected mRNAs. EMBO J 2012; 31: 3745-56.
35. Silvera D, Formenti SC, Schneider RJ. Translational control in cancer. Nat Rev Cancer 2010; 10: 254-66.
36. Barna M, Pusic A, Zollo O, Costa M, Kondrashov N, Rego E, et al. Suppression of Myc oncogenic activity by ribosomal protein haploinsuffi ciency. Nature 2008; 456: 971-5.
37. Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A, et al. The mutational landscape of head and neck squamous cell carcinoma. Science 2011; 333: 1157-60.
38. Hsieh AC, Liu Y, Edlind MP, Ingolia NT, Janes MR, Sher A, et al. The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature 2012; 485: 55-61.
39. Thoreen CC, Chantranupong L, Keys HR, Wang T, Gray NS, Sabatini DM. A unifying model for mTORC1-mediated regulation of mRNA translation. Nature 2012; 485: 109-13.
40. Fukuchi-Shimogori T, Ishii I, Kashiwagi K, Mashiba H, Ekimoto H, Igarashi K. Malignant transformation by overproduction of translation initiation factor eIF4G. Cancer Res 1997; 57: 5041-4.
41. Chen L, Aktas BH, Wang Y, He X, Sahoo R, Zhang N, et al. Tumor suppression by small molecule inhibitors of translation initiation. Oncotarget 2012; 3: 869-81.
42. Noel P, Cartwright IL. A Sec62p-related component of the secretory protein translocon from Drosophila displays developmentally complex behavior. EMBO J 1994; 13: 5253-61.
43. Zender L, Spector MS, Xue W, Flemming P, Cordon-Cardo C, Silke J, et al. Identifi cation and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 2006; 125: 1253-67.
44. Lu Z, Zhou L, Killela P, Rasheed AB, Di C, Poe WE, et al. Glioblastoma proto-oncogene SEC61gamma is required for tumor cell survival and response to endoplasmic reticulum stress. Cancer Res 2009; 69: 9105-9111.
45. Radi M, Falchi F, Garbelli A, Samuele A, Bernardo V, Paolucci S, et al. Discovery of the first small molecule inhibitor of human DDX3 specifically designed to target the RNA binding site: towards the next generation HIV-1 inhibitors. Bioorg Med Chem Lett 2012; 22: 2094-2098.
46. Robinson JT, Thorvaldsdottir H, Winckler W, Guttman M, Lander ES, Getz G, et al. Integrative genomics viewer. Nat Biotechnol 2011; 29: 24-26.
47. Elenbaas B, Spirio L, Koerner F, Fleming MD, Zimonjic DB, Donaher JL, et al. Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev 2001; 15: 50-65.
48. Morgenstern JP, Land H. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res 1990; 18: 3587-96.
49. Moffat J, Grueneberg DA, Yang X, Kim SY, Kloepfer AM, Hinkle G, et al. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 2006; 124: 1283-98.
50. CCSB. The CCSB human ORFeome collection. [cited 2012 Dec 22]. Available from: http://horfdb.dfci.harvard.edu.
51. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profi les. Proc Natl Acad Sci U S A 2005; 102: 15545-50.
52. Peng J, Gygi SP. Proteomics: the move to mixtures. J Mass Spectrom2001; 36: 1083-91.
53. Yates JR, Eng JK, McCormack AL, Schieltz D. Method to correlatetandem mass spectra of modifi ed peptides to amino acid sequences in the protein database. Anal Chem 1995; 67: 1426-36.
54. Broad-Novartis Cancer Cell Line Encyclopedia (CCLE). [cited 2012Dec 22]. Available from: www.broadinstitute.org/ccle/home.
55. GenePattern. [cited 2012 Dec 22]. Available from: http://genepattern.broadinstitute.org.